晨光生物：取得专利证书，专利名称为“一种以万寿菊花药为外植体的诱导培养基及诱导方法”等

Group 1 - The core point of the article is that Chenguang Biotech has received patent and trademark certifications from the National Intellectual Property Administration and the European Patent Office for its innovative products [1] - Chenguang Biotech's revenue composition for the year 2024 is entirely derived from the agricultural and sideline food processing industry, specifically plant extracts, accounting for 100% of its revenue [1] - The current market capitalization of Chenguang Biotech is reported to be 5.9 billion yuan [2]